Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
- PMID: 29109555
- DOI: 10.1038/nrmicro.2017.128
Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
Abstract
Co-infection with Mycobacterium tuberculosis is the leading cause of death in individuals infected with HIV-1. It has long been known that HIV-1 infection alters the course of M. tuberculosis infection and substantially increases the risk of active tuberculosis (TB). It has also become clear that TB increases levels of HIV-1 replication, propagation and genetic diversity. Therefore, co-infection provides reciprocal advantages to both pathogens. In this Review, we describe the epidemiological associations between the two pathogens, selected interactions of each pathogen with the host and our current understanding of how they affect the pathogenesis of TB and HIV-1/AIDS in individuals with co-infections. We evaluate the mechanisms and consequences of HIV-1 depletion of T cells on immune responses to M. tuberculosis. We also discuss the effect of HIV-1 infection on the control of M. tuberculosis by macrophages through phagocytosis, autophagy and cell death, and we propose models by which dysregulated inflammatory responses drive the pathogenesis of TB and HIV-1/AIDS.
Similar articles
-
HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome.Semin Immunopathol. 2016 Mar;38(2):185-98. doi: 10.1007/s00281-015-0532-2. Epub 2015 Sep 30. Semin Immunopathol. 2016. PMID: 26423994 Free PMC article. Review.
-
Mitochondrial Metabolism in Alveolar Macrophages of Patients Infected with HIV, Tuberculosis, and HIV/Tuberculosis.AIDS Res Hum Retroviruses. 2024 Mar;40(3):148-157. doi: 10.1089/AID.2023.0064. Epub 2023 Nov 14. AIDS Res Hum Retroviruses. 2024. PMID: 37885217 Review.
-
Multinomial modelling of TB/HIV co-infection yields a robust predictive signature and generates hypotheses about the HIV+TB+ disease state.PLoS One. 2019 Jul 15;14(7):e0219322. doi: 10.1371/journal.pone.0219322. eCollection 2019. PLoS One. 2019. PMID: 31306460 Free PMC article.
-
HIV-Mycobacterium tuberculosis co-infection: a 'danger-couple model' of disease pathogenesis.Pathog Dis. 2014 Mar;70(2):110-8. doi: 10.1111/2049-632X.12108. Epub 2013 Nov 25. Pathog Dis. 2014. PMID: 24214523 Review.
-
Changing concepts of "latent tuberculosis infection" in patients living with HIV infection.Clin Dev Immunol. 2011;2011:980594. doi: 10.1155/2011/980594. Epub 2010 Sep 26. Clin Dev Immunol. 2011. PMID: 20936108 Free PMC article.
Cited by
-
Bayesian modeling of spatiotemporal patterns of TB-HIV co-infection risk in Kenya.BMC Infect Dis. 2019 Oct 28;19(1):902. doi: 10.1186/s12879-019-4540-z. BMC Infect Dis. 2019. PMID: 31660883 Free PMC article.
-
Modulation of Cystatin C in Human Macrophages Improves Anti-Mycobacterial Immune Responses to Mycobacterium tuberculosis Infection and Coinfection With HIV.Front Immunol. 2021 Nov 18;12:742822. doi: 10.3389/fimmu.2021.742822. eCollection 2021. Front Immunol. 2021. PMID: 34867965 Free PMC article.
-
Mycobacterium tuberculosis Induces Irg1 in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis.Front Cell Infect Microbiol. 2022 May 2;12:862582. doi: 10.3389/fcimb.2022.862582. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35586249 Free PMC article.
-
The Dual-Targeting Activity of the Metabolite Substrate of Para-amino Salicyclic Acid in the Mycobacterial Folate Pathway: Atomistic and Structural Perspectives.Protein J. 2020 Apr;39(2):106-117. doi: 10.1007/s10930-020-09885-1. Protein J. 2020. PMID: 32086691
-
Brassicasterol with Dual Anti-Infective Properties against HSV-1 and Mycobacterium tuberculosis, and Cardiovascular Protective Effect: Nonclinical In Vitro and In Silico Assessments.Biomedicines. 2020 May 24;8(5):132. doi: 10.3390/biomedicines8050132. Biomedicines. 2020. PMID: 32456343 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
